• Paula Gardiner, Anna Sophia Lestoquoy, Katherine Gergen-Barnett, Brian Penti, Laura F White, Robert Saper, Lisa Fredman, Sarah Stillman, N Lily Negash, Pamela Adelstein, Ivy Brackup, Christine Farrell-Riley, Karim Kabbara, Lance Laird, Suzanne Mitchell, Timothy Bickmore, Ameneh Shamekhi, and Jane M Liebschutz.
• Department of Family Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, United States. Electronic address: paula.gardiner@bmc.org.
• Contemp Clin Trials. 2017 Mar 1; 54: 25-35.

BackgroundGiven the public health crisis of opioid overprescribing for pain, there is a need for evidence-based non pharmacological treatment options that effectively reduce pain and depression. We aim to examine the effectiveness of the Integrative Medical Group Visits (IMGV) model in reducing chronic pain and depressive symptoms, as well as increasing pain self-management.MethodsThis paper details the study design and implementation of an ongoing randomized controlled trial of the IMGV model as compared to primary care visits. The research aims to determine if the IMGV model is effective in achieving: a) a reduction in self-reported pain and depressive symptoms and 2) an improvement in the self-management of pain, through increasing pain self-efficacy and reducing use of self-reported pain medication. We intend to recruit 154 participants to be randomized in our intervention, the IMGV model (n=77) and to usual care (n=77).ConclusionsUsual care of chronic pain through pharmacological treatment has mixed evidence of efficacy and may not improve quality of life or functional status. We aim to conduct a randomized controlled trial to evaluate the effectiveness of the IMGV model as compared to usual care in reducing self-reported pain and depressive symptoms as well as increasing pain management skills.Copyright © 2016 Elsevier Inc. All rights reserved.

30 keywords...

hide…